April 14, 2023 — Genetesis, Inc., the leader in biomagnetic cardiac imaging solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device designation for its flagship imaging solution, CardioFlux MCG, to identify myocardial ischemia in patients who may be suffering from coronary microvascular disease (CMD).

April 14, 2023 — A new twist on a drug used to treat alcohol use disorder could double up as a treatment for stroke, the leading cause of disability and the third leading cause of death in the United States. Called “Carb” for short, this new formulation is designed to treat ischemic stroke, protect brain tissue against injury and minimize the size of a brain infarct. About 87 percent of all strokes are ischemic stroke, which occurs when a vessel supplying blood to the brain is obstructed.  

April 14, 2023 — Deaths from cardiovascular disease are elevated on polluted days and for two days afterwards, according to research presented at ESC Preventive Cardiology 2023, a scientific congress of the European Society of Cardiology (ESC),1 and published in the 

April 13, 2023 — Wireless or leadless pacemakers, commonly implanted in adults, may be a safe and effective short-term option for 

April 13, 2023 — A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population.

April 12, 2023 — Results from the Precision Hypertension Care Study (PHYSIC) showed that personalized blood pressure treatment had the potential to lower systolic blood pressure by an additional 4.4 mm Hg, as published April 11 in the 

April 11, 2023 — Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced a strategic sales partnership with CompleMed, LLC, a national sales organization focusing on the US cardiology market. This partnership expands Acarix sales organization with 16 additional sales teams covering initially 30 new states across the United States, reaching a current geographic market coverage of 43 states. 

April 11, 2023 — A newly-published study in the Journal of the American College of Cardiology, JACC, the flagship journal of the American College of Cardiology (ACC), focuses on the impact of moderate exercise in patients using statins.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now